NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) — Cycle for Survival, the movement to beat rare cancers, made history by surpassing $300 million in total funds raised through its signature stationary-cycling events. Since 2007, more than 1 million participants worldwide, including patients, caregivers, survivors, as well as Memorial Sloan Kettering clinicians, researchers, staff and trustees have taken part in events to raise money for rare cancer research at MSK. This new milestone highlights the unwavering determination of every rider, donor, and supporter, along with the tremendous collaborative effort between the entire Cycle for Survival community.
The $300 million raised by the Cycle for Survival community has equipped hundreds of MSK physicians, scientists, and researchers to pursue bold ideas and transform how cancer is diagnosed and treated. Funding from Cycle for Survival has directly supported numerous MSK innovations, including: MSK-IMPACT®, a diagnostic tool that can detect mutations and other critical changes in the genes of rare cancers
Theranostics, a form of rare cancer treatment that harnesses the power of unique radioactive compounds to deliver therapeutics at the point of diagnosis
Immunotherapy, which uses the immune system to attack cancer cells, in much of the same way that it attacks bacteria or viruses
“Two of the most important advancements that have basically kept me alive in the past year were funded entirely by Cycle for Survival,” said David Ingerman, an MSK patient and Cycle for Survival participant. All of the money raised by Cycle for Survival is allocated within six months following […]